Leonetti, A., Boni, L., Gnetti, L., Cortinovis, D. L., Pasello, G., Mazzoni, F., Bearz, A., Gelsomino, F., Passiglia, F., Pilotto, S., Metro, G., Delmonte, A., Cecere, F. L., Bertolini, F., Toschi, L., Parra, H. S., Ricciardi, S., Bria, E., Tognetto, M., Tiseo, M. (2025). Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC: Final analysis of ALNEO phase II trial (GOIRC-01-2020-ML42316).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8015